Expanding Diagnostic Capabilities Applied Microarrays has recently launched improved and advanced microarray scanners, indicating a focus on enhancing diagnostic and laboratory testing solutions, presenting an opportunity to offer complementary diagnostic equipment or automation tools.

Strategic Acquisition The acquisition by Schott AG in September 2021 reinforces Applied Microarrays' growth trajectory and industry positioning, opening avenues for joint marketing, integrated solutions, and expanded product offerings in biosensing and microarray development.

High-Profile Partnerships Collaborations with clinical diagnostic companies like Novacyt and Primerdesign highlight opportunities to develop custom assays and SNP testing solutions, which could be associated with enhanced sample processing or detection technologies.

Innovation Focus With recent launches of microarray scanners and the development of microfluidic devices like the X-Gene 3, there is a strategic emphasis on advancing genomic and proteomic research tools, suggesting potential sales of innovative components or related laboratory systems.

Industry Positioning As a specialized contract manufacturer with a boutique size, Applied Microarrays presents opportunities to offer tailored manufacturing services, including material selection and device fabrication, to companies seeking flexible production partners in biotechnology and diagnostics.